MiNK Therapeutics Inc.
Organization details
- Legal name
- MiNK Therapeutics Inc.
- Former names
- AgenTus Therapeutics, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- New York
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- INKT
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001840229
Board of directors
-
Barbara Ryan · DirectorSince 2023
-
Brian Corvese · DirectorSince 2023
-
Garo H. Armen · DirectorSince 2023
-
Jennifer Buell · Director · Chief Executive OfficerSince 2023
-
John Baldoni · DirectorSince 2023
-
John Bradley Holcomb · DirectorSince 2025
-
Peter Behner · DirectorSince 2023
-
Robert Peter Kadlec · DirectorSince 2024
-
Ulf Wiinberg · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 17, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.6%
-
98.6%
-
99.4%
Board connections
5 of this board's directors also sit on 4 other boards. 4 are in the same sector.
-
Agenus Inc. Same sectorvia Brian Corvese, Garo H. Armen, Jennifer Buell and Ulf Wiinberg
-
Azitra Inc Same sectorvia Barbara Ryan
-
INVO Fertility Inc. Same sectorvia Barbara Ryan
-
Indivior Pharmaceuticals Inc. Same sectorvia Barbara Ryan
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $46,620
- 8 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 1, 2026 | Peter Behner Director | Grant or award | +1,485 | $10.95 | $16,261 |
| Sep 1, 2026 | Brian Corvese Director | Grant or award | +1,633 | $10.95 | $17,881 |
| Sep 1, 2026 | John Bradley Holcomb Director | Grant or award | +1,233 | $10.95 | $13,501 |
| Sep 1, 2026 | Barbara Ryan Director | Grant or award | +1,622 | $10.95 | $17,761 |
| Sep 1, 2026 | Ulf Wiinberg Director | Grant or award | +1,279 | $10.95 | $14,005 |
| Jun 4, 2026 | Barbara Ryan Director | Open-market sale | −500 | $12.68 | $6,340 |
| Jun 4, 2026 | Barbara Ryan Director | Open-market sale | −1,000 | $12.80 | $12,800 |
| Jun 1, 2026 | John Bradley Holcomb Director | Grant or award | +1,091 | $12.38 | $13,507 |
| Jun 1, 2026 | Barbara Ryan Director | Grant or award | +1,434 | $12.38 | $17,753 |
| Jun 1, 2026 | Brian Corvese Director | Grant or award | +1,444 | $12.38 | $17,877 |
| Jun 1, 2026 | Peter Behner Director | Grant or award | +1,313 | $12.38 | $16,255 |
| Jun 1, 2026 | Ulf Wiinberg Director | Grant or award | +1,131 | $12.38 | $14,002 |
| Mar 10, 2026 | Barbara Ryan Director | Open-market sale | −300 | $15.28 | $4,584 |
| Mar 10, 2026 | Barbara Ryan Director | Open-market sale | −500 | $15.57 | $7,785 |
| Mar 10, 2026 | Barbara Ryan Director | Open-market sale | −500 | $15.30 | $7,650 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about MiNK Therapeutics Inc.
Who is the CEO of MiNK Therapeutics Inc.?
Jennifer Buell is MiNK Therapeutics Inc.'s Chief Executive Officer.
How many directors are on MiNK Therapeutics Inc.'s board?
MiNK Therapeutics Inc.'s board has 9 directors: Barbara Ryan, Brian Corvese, Garo H. Armen, Jennifer Buell, John Baldoni, John Bradley Holcomb, Peter Behner, Robert Peter Kadlec and Ulf Wiinberg.
Are MiNK Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, MiNK Therapeutics Inc. insiders made no open-market purchases and sold $46,620 of shares in 8 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="mink-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.